Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

Lester-Coll Quoted in Renal & Urology News Article on SBRT to Treat Prostate Cancer

October 16, 2023 by Lucy Gardner Carson

(OCTOBER 16, 2023) Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.

Radiation oncologist Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center

(OCTOBER 16, 2023) Radiation oncologist Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.

SBRT should be considered a new standard of care for low-and favorable-intermediate-risk prostate cancer, investigators concluded based on findings from the international phase 3 PACE-B trial presented at the American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting in San Diego.

Lester-Coll said the excellent outcomes observed in PACE-B reflect advances in patient immobilization, treatment planning, and image-guidance. “It’s a very important study in that the stereotactic option offers convenience and cost-effectiveness, providing patients with shorter, more accessible treatment while optimizing health care resources,” he said.

Read full story at Renal & Urology News